Cat.#: ACPP-1342
| Despition | ORP150 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1503 | Human RTP4 Protein (AC1503) | 5 µg | inquiry |
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
| ACPP-1224 | LAMP1 Blocking Peptide (AC1224) | 250 µg | inquiry |
| ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg | inquiry |
| ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.